These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24313193)

  • 1. [New aspects of the pathogenesis and classification of basal-like breast carcinoma].
    Gorelik MZ; Andreeva IuIu; Zavalishina LÉ
    Arkh Patol; 2013; 75(4):48-53. PubMed ID: 24313193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phenotypic spectrum of basal-like breast cancers: a critical appraisal.
    Fadare O; Tavassoli FA
    Adv Anat Pathol; 2007 Sep; 14(5):358-73. PubMed ID: 17717437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?
    van Deurzen CH; Lee AH; Gill MS; Menke-Pluijmers MB; Jager A; Ellis IO; Rakha EA
    J Pathol; 2011 Aug; 224(4):434-7. PubMed ID: 21462188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
    Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
    J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal-like Breast Cancers: From Pathology to Biology and Back Again.
    Gusterson B; Eaves CJ
    Stem Cell Reports; 2018 Jun; 10(6):1676-1686. PubMed ID: 29874626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular alterations in metaplastic breast carcinoma.
    Cooper CL; Karim RZ; Selinger C; Carmalt H; Lee CS; O'Toole SA
    J Clin Pathol; 2013 Jun; 66(6):522-8. PubMed ID: 23372178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deconstructing the molecular portrait of basal-like breast cancer.
    Yehiely F; Moyano JV; Evans JR; Nielsen TO; Cryns VL
    Trends Mol Med; 2006 Nov; 12(11):537-44. PubMed ID: 17011236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary culture of breast cancer: a model system for epithelial-mesenchymal transition and cancer stem cells.
    Nishikata T; Ishikawa M; Matsuyama T; Takamatsu K; Fukuhara T; Konishi Y
    Anticancer Res; 2013 Jul; 33(7):2867-73. PubMed ID: 23780972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
    Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
    Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
    Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer stem cells: an update.
    Iqbal J; Chong PY; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.
    Floor S; van Staveren WC; Larsimont D; Dumont JE; Maenhaut C
    Oncogene; 2011 Nov; 30(46):4609-21. PubMed ID: 21643013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal carcinoma of the breast revisited: an old entity with new interpretations.
    Korsching E; Jeffrey SS; Meinerz W; Decker T; Boecker W; Buerger H
    J Clin Pathol; 2008 May; 61(5):553-60. PubMed ID: 18326009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.
    Clarke C; Sandle J; Lakhani SR
    J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):273-80. PubMed ID: 16807806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of breast cancer cells in patients with distant metastasis: the finishing touches?
    Ito Y; Iwase T; Hatake K
    Breast Cancer; 2012 Jul; 19(3):206-11. PubMed ID: 21526426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative approaches to cancer stem cells and epithelial-mesenchymal transition.
    Turner C; Kohandel M
    Semin Cancer Biol; 2012 Oct; 22(5-6):374-8. PubMed ID: 22609094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of breast cancer stem cells with fibrous scaffolds.
    Feng S; Duan X; Lo PK; Liu S; Liu X; Chen H; Wang Q
    Integr Biol (Camb); 2013 May; 5(5):768-77. PubMed ID: 23529778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.